ASPIRA PATHLAB & DIAGNOSTICS
|
The Current P/B Ratio of ASPIRA PATHLAB & DIAGNOSTICS is 10.13.
| Share Price | ₹119.7 | Jun 17,2026 |
| Market Cap | ₹123.3 Cr | |
| Book Value | ₹12.2 Cr | Mar2025 - Consolidated Results |
| Price/Book | 10.13x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of ASPIRA PATHLAB & DIAGNOSTICS
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹123.3 Cr] as on Jun 17,2026
(/) Book Value [ ₹12.2 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 10.13x ]
Thus, for ASPIRA PATHLAB & DIAGNOSTICS , the investors are currently willing to pay '10.13 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of ASPIRA PATHLAB & DIAGNOSTICS !
The chart below summarizes the trend in P/B Ratio of ASPIRA PATHLAB & DIAGNOSTICS over the last five years.
Historical PB (Price/Book ) ratio chart of ASPIRA PATHLAB & DIAGNOSTICS
PB Ratio Performance Analysis for ASPIRA PATHLAB & DIAGNOSTICS
- ASPIRA PATHLAB & DIAGNOSTICS 's p/b ratio for fiscal years ending Mar2025 to Mar2024 averaged 5.18x.
- ASPIRA PATHLAB & DIAGNOSTICS 's operated at median p/b ratio of 7.21x from fiscal years ending March 2018 to 2022.
- Looking back at the last 2 fiscal years, ASPIRA PATHLAB & DIAGNOSTICS 's p/b ratio peaked in Mar2025 at 7.21x.
- ASPIRA PATHLAB & DIAGNOSTICS 's p/b ratio hit its five-year low in Mar2024 of 3.15x.
How does ASPIRA PATHLAB & DIAGNOSTICS 's P/B Ratio benchmark against top 10 peers in Hospital & Healthcare Services Industry?
| Peer Comparison (Hospital & Healthcare Services Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| ASPIRA PATHLAB & DIAGNOSTICS | 12.17 | 10.13 | 123.3 |
| APOLLO HOSPITALS ENTERPRISE LTD | 9,472.30 | 12.80 | 121,241.0 |
| MAX HEALTHCARE INSTITUTE LTD | 10,746.60 | 9.29 | 99,869.4 |
| FORTIS HEALTHCARE LTD | 9,895.55 | 7.25 | 71,709.7 |
| ASTER DM HEALTHCARE LTD | 4,575.86 | 8.68 | 39,716.6 |
| NARAYANA HRUDAYALAYA LTD | 4,537.26 | 8.30 | 37,662.7 |
| GLOBAL HEALTH LTD | 3,961.57 | 8.51 | 33,732.1 |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD | 2,247.40 | 14.18 | 31,863.1 |
| DR LAL PATHLABS LTD | 2,508.20 | 11.03 | 27,668.6 |
| DR AGARWALS HEALTH CARE LTD | 2,025.46 | 6.94 | 14,056.6 |
| RAINBOW CHILDRENS MEDICARE LTD | 1,648.07 | 8.89 | 14,656.0 |
Hospital & Healthcare Services Industry Benchmark (Top 10) PB Analysis vs ASPIRA PATHLAB & DIAGNOSTICS 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 6.94x |
| Max industry PB | 14.18x |
| Median industry PB | 8.89x |
| Average industry PB | 9.64x |
You may also like the below Video Courses